Owing to the role of the LIMKs in regulating cytoskeletal dynamics and their position as downstream effectors of numerous signaling cascades, we consider LIMK inhibition to be a promising approach for the treatment of cardiovascular disorders. This evidence concerns the gene LIMK1 and cardiovascular disorder.